34 participants
Single-arm, Phase II Clinical Study Evaluating the Safety and Efficacy of Sintilimab Combined With IBI-310 and Chemotherapy as Neoadjuvant Therapy for Locally Advanced Rectal Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-06
- Start Date:
- 2026-05-29
- Completion:
- 2026-11-30
Conditions
- MSI-H/dMMR Locally Advanced Rectal Adenocarcinoma
Interventions
- DRUG
No Results Yet